ISPUB.com / IJPHARM/5/2/12298
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Pharmacology
  • Volume 5
  • Number 2

Original Article

Anxiolytic Activity Of Seed Extract Of Caesalpinia Bonducella (Roxb) In Laboratory Animals

A Ali, N Venkat Rao, M Shalam, T Shivaraj Gouda, J Babu, S Shantakumar

Keywords

anti-anxiety activity, c. bonducella, petroleum ether extract, seed kernel

Citation

A Ali, N Venkat Rao, M Shalam, T Shivaraj Gouda, J Babu, S Shantakumar. Anxiolytic Activity Of Seed Extract Of Caesalpinia Bonducella (Roxb) In Laboratory Animals. The Internet Journal of Pharmacology. 2007 Volume 5 Number 2.

Abstract

In the traditional system of Indian medicine C.bonducella is widely used for its antipyretic, antiperiodic, anticonvulsant and antiparalytic activities. The present study was aimed to explore the anxiolytic activities of seed extract of C.bonducella in experimental animals, mice and rats. In Stair-case model, all the three doses i-e low, medium and high 400, 600 and 800mg/kg of PECB had showed a significant and dose dependent Anxiolytic activity by increasing the number of steps climbed, without any significant effect on rearings by all these three doses. Similarly in EPM model medium and high doses, but not the low dose of PECB had significantly enhanced both number of entries and time spent in open arms and decreased in number of entries and time spent in closed arms. In Hole- board model, medium and high doses 600 and 800mg/kg but not the low dose 400mg/kg of PECB had significantly enhanced the number, latency and the duration of head dipping but not the rearings. However in LDT model high doses 800mg/kg of PECB had significantly exhibited anxiolytic activity by increasing time spent, number of crossings in light compartment and decreased the time spent in dark compartment and decreased the number of rearings in both light and dark compartments. In OFT models, medium and high doses 600 and 800mg/kg but not the low dose 400mg/kg of PECB had significantly enhanced total locomotion, central locomotion, number of grooming but the immobility time has drastically reduced. All doses of PECB have not exerted any significant effect with rearing, defecation and urination. Moreover in Mirror-chamber model of anxiety, both medium and high doses 600 and 800mg/kg but not the low dose 400mg/kg of PECB had significantly reduced the time latency to enter in to the mirror chamber and increased the number of entries and time spent in the chamber. Thus the result recorded with above experimental models confirms the anxiolytic activity of PECB.

 

Introduction

In day today life of stress and strain there is a dire need for agents having neuroprotective and neuropharmacological activity enhancing learning and memory caliber of the brain 1 . Stress involves complex biochemical, neurological and immunological mechanisms and plays a crucial role in the genesis/progression of a variety of disease states ranging from psychiatric disorders like depression and anxiety, immunosupression, endocrine disorders including diabetes mellitus, impotency and cognitive dysfunctions 2.

Anxiety related disorders such as generalized anxiety, panic, obsessive-compulsion, phobias or post traumatic stress disorders are common and major cause of disability 3 and 1/8 th of the total population worldwide affected with anxiety and became a very important area of research interest in psychopharmology 4 . Anxiety is also an obvious component of many psychiatric and medical conditions 5 .

During the last two decades, pharmacotherapy with psychoactive drugs has become management of anxiety, stress and psychomotic disorders. Traditionally pharmacological research in the area of anxiety and stress treatment is very much influenced by the availability of anxiolytic drugs. Throughout history recorded, ethanol was and is the standard drug for treatment of feelings of discomfort, tension, anxiety and stress 6 .

Though barbiturates were dominant agents from 1900-1950 because of considerable concern about their safety lead to the search of better alteration. Moreover benzodiazepines (bdz) as anxiolytic agents have brought tremendous progress in understanding the physiological, biochemical and pathological status of the disease. However the use of tranquillizer and psychotropic drugs leads to variety of autonomic, neurologic and hematopoietic disorder, but these agents primarily relieve the symptoms and offer a palliative relief of a temporary nature 7 .

In recent years use of alternative medicine in particular, derived from plant have been increased in a number of patient with condition that affect the mind 8 .

In traditional system of indian medicine (Ayurveda) caesalpinia bonducella (roxb.) is widely used for its antipyretic, antiperiodic, anthelmintic, anti-inflammatory, antimalarial and also for various ailments like skin diseases, leprosy, hydrocele, orchitis, convulsions, paralysis and similar nervous complaints 9 .

Materials and Methods

Animals

Swiss albino mice of either sex weighing between 20-30g were procured from Shri Venkateswara Enterprises, Bangalore for experimental purpose. All the animals were acclimatized for seven days under standard husbandry conditions i.e.; room temperature of 24 0 ± 10 0 C; relative humidity 45-55% and a 12:12h light/ dark cycle. 40,41 The animals had free access to standard rat pellet diet (Amrut laboratories, Pranava Agro Industries Ltd., Sangli, India), with water provided ad libitum under strict hygienic conditions. Each experimental group had separate set of animals and care was taken to ensure that animals used for one response were not employed elsewhere. Animals were habituated to laboratory conditions for 48 hours prior to experimental protocol to minimize if any of non-specific stress. The approval of the Institutional Animal Ethical Committee (IAEC) of V. L. College of Pharmacy Raichur (Karnataka) was taken prior to the experiments. All the protocols and the experiments were conducted in strict compliance according to ethical principles and guidelines provided by Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), with registration number 557/02/c/CPCSEA.

Preparation of seed extracts of

Seed powder of C.bonducella will be successively extracted with petroleum ether, ethanol, methanol and water. Each time before extracting with the next solvent, marc will be dried in Hot air-oven below 50 0 C. Finally the marc will be macerated with chloroform water (i.e.; chloroform acts as a preservative) for 24 hrs to obtain the aqueous extract. Each extract will be concentrated by distilling off the solvent and then evaporating to dryness on the water bath.

Drugs

Diazepam [Ranbaxy Laboratories Ltd, Mumbai, India], Tween-80 [s.d.fine Chem Ltd. Mumbai], Petroleum Ether [The Ugar Sugar Works Ltd. Ugar Khurd, Belgaum] and Distilled water [Mysore Petro Chemicals, Raichur, India].

Preliminary phytochemical Screening ,,

The preliminary phytochemical investigations will be carried out with the seed extract of C.bonducella (PE) for qualitative identification of phytoconstituents.

Experimental design

Acute toxicity test of

The acute toxicity of C. bonducella will be determined by using albino mice of either sex (20-25 g), maintained under standard conditions. The animals will be fasted for 3 hr prior to the experiment. Animals will be administered with single dose of seed extract of C. bonducella and observed for its mortality upto 48 hr study period (short term toxicity). Based on the short-term toxicity profile, the next dose will be determined as per OECD guidelines No 425. From the LD50 dose 1/20, 1/10 and 1/5 th doses are to be selected and considered as low, medium and high dose respectively.

Grouping of animals and treatment schedule

Male albino mice (22-25g) and wistar rats (150-200g) were divided into following groups each consisting of six animals.

Group A - Normal control (2% gum acacia p.o)

Group B - Standard (Diazepam 3mg/kg p.o)

Group C - Seed extract of C.bonducella (400mg/kg p.o)

Group D - Seed extract of C.bonducella (600 mg/kg p.o)

Group E - Seed extract of C.bonducella (800 mg/kg p.o)

All the drugs were administered to the respective groups in all the models for a period of eight days and experiments were performed one hour after the administration of last dose.

All the experiments were carried in a sound attenuated dark room. After test with each animal, all the apparatus was cleaned with 5% alcohol in order to eliminate any olfactory cues which might modify the behavior of the next animal.

Staircase test in mice

The staircase is composed of five identical steps 2.5 cm high, 10 cm wide and 7.5 cm deep. The internal height of the walls is constant along the whole length of the staircase. Each animal is used only once.ment. At the end of experimental period mice were placed individually on the floor of the box with its back to the staircase. Total number of steps climbed and total number of rearings were recorded over a period of 3 min. A step is considered to be climbed only if the mouse has placed all four paws on the step15 .

Elevated Plus-Maze Test in mice

The plus-maze apparatus comprises of two open arms (16×5cm) and two closed arms (16×5×12cm) that extend from a common central platform (5×5cm). The entire maze is elevated to a height of 25cms above the floor level. Mice were placed individually in the center of the maze facing one of the enclosed arms for recording various parameters in a period of 5 min.16,17,18,19

Hole-board test in rats

The apparatus used in this model consists of wooden chamber (40x40x25 cm) with 16 holes (diameter 3 cm) on the floor, elevated from the ground so that the rats could peep through the holes each rat will be placed individually in the apparatus for recording following parameters, latency to the first head dips, no. of head dips in the holes, total time spent with the head dips, no. of rearings, no. of defecation units.20

Light-dark model transition test in mice

The light-dark apparatus consists of two-compartment chamber (40×60×20cm/h) comprising of a brightly illuminated area (40×40cm) and a dark area (40×20 cm) separated by a wall with a round hole (7 cm diameter) will be used. Mice were placed individually in the illuminated part of the cage and following parameters were recorded during the test session of 5 min, total no. of crossings, no. crossings between the light and dark area, total time spent in the illuminated part of the cage, time spent in the dark part of the cage, no. of rearings in illuminated part of the cage, no. of rearings in dark part of the cage, no. of defecation units. 21,22,23

Statistical analysis

The values were expressed as mean ± SEM from 6 animals. The results were subjected to statistical analysis by using ANOVA followed by Dennett's- t -test test to calculate the significance difference if any among the groups. P<0.05 was considered significant.

Results

Effect of on mice in Stair-case test

Three different doses of PECB (400, 600 and 800mg/kg) were subjected for anxiolytic activity using Stair-case test in mice. These doses when administered orally daily once for 7 days, high and medium doses (800&600mg/kg) has showed significant increase in no. of steps climbed and rearings dose dependently when compared to control. However, PECB at 400 mg/kg had not shown any significant effect with no. of rearings. Standard drug diazepam (2mg/kg) had exhibited significant anxiolytic effect.

Figure 1
Table 1: Anxiolytic effect of PECB on stair-case model in mice

Effect of on mice in Elevated plus maze

Diazepam has long been reported for its anxiolytic activity in mice with the EPM model. In our study also, a significant anxiolytic effect was recorded with diazepam as increased number of entries in to open and decreased number of entries in to closed arms and with increased time spent in open and central platform but not in closed arms. Insignificant effect was recorded with total number of entries in both the arms when compared to control. In chronic study when different doses of PECB i.e. 400, 600 and 800mg/kg were administered orally daily once for seven days, it was found that lower dose (400mg/kg) increased the number of entries and time spent in the open arm ,central platform and decreased the time spent in closed arm as compared to control group. Where as medium and high doses (400 and 800mg/kg) had increased the number of entries and time spent in the open arm, central platform and decreased the number of entries and time spent in closed arm as compared to control group and exhibited statistically significant activity. No significant effect was observed with total number of entries with all doses. Among these, low dose (400mg/kg) had increased time spent in central platform when compared to medium, high and standard doses respectively.

Figure 2
Table 2: Anxiolytic effect of PECB with elevated plus maze model in mice

Effect of on mice in Hole- board model

Three different doses of PECB (400, 600 and 800mg/kg) were subjected for anxiolytic activity using HB- model in mice. These doses when administered orally daily once for 7 days, high and medium doses (800&600mg/kg) but not low dose (400mg/kg) has shown significant increase in latency to the 1 st head dips, number of head dips and time spent in head dips. A significant increase in number of rearing was observed in both medium and high doses as compared to control group. Defecation units have significantly reduced with high dose but not with low and medium doses as compared to control group. Standard drug diazepam (2mg/kg) had exhibited significant anxiolytic activity.

Figure 3
Table 3: Anxiolytic effect of PECB with Hole Board Model in rats

Effect of on mice in Light-Dark transition test

Three different doses of PECB (400, 600 and 800mg/kg) were subjected for anxiolytic activity using LDT model in mice. These doses when administered orally daily once for 7 days, high dose (800mg/kg) but not the low and medium doses (400 & 800mg/kg) had produced an increase in number of crossings and time spent in light box and decrease in the number of rearings in both light and dark compartments. Defecation boli were not significantly altered with these different doses of PECB when compared to control group. High dose had statistically showed significant anxiolytic activity and Standard drug diazepam (2mg/kg) had exhibited significant anxiolytic activity.

Figure 4
Table 4: Anxiolytic effect of PECB in mice in Light-dark model

Discussion

The stair-case test has been proven as a simple and reliable method for screening of anxiolytics in several laboratories. The stair-case test for evaluating anxiolytic activity was originally described for rats 24 . When introduced into a novel environment, rodents experience anxiety manifested by increased vigilance and behavioral activity. In the stair-case paradigm, step-climbing is purported to reflect exploratory or locomotor activity, while rearing behaviors is an index of anxiety state. The number of rearing and steps climbed are recorded in a 5 min period. The test was modified for rapid screening of anxiolytic activity in mice 25 .

When compared to control PECB with all the three doses i-e, low, medium and high (400, 600 and 800mg/kg) tested had showed a significant increase in number of steps climbed up and rearings dose dependently. However, PECB at 400 mg/kg had not shown any significant effect with no. of rearings. Standard drug diazepam (2mg/kg) had exhibited significant anxiolytic effect.

The elevated plus maze is a well-established animal model for testing anxiolytic drugs 26,27 . A standard anxiolytic drug diazepam used clinically is also employed in behavioral pharmacology as a reference compound for inducing anxiolytic like effects 28 , even when the compound being screened does not act via benzodiazepine receptors.

Although orginal validation of the EPM was performed in rats 35 , it has also been found to be selectively sensitive to the effects of anxiolytic and anxiogenic drugs in mice 30 .

The EPM test is based on a premise where the exposure to an EPM evoked an approach-avoidance conflict that was considerably stronger than evoked by the exposure to an enclosed arm 34 . The decrease in aversion to the open arm is the result of an anxiolytic effect, expressed by the increased time spent and entries in to the open arm. The primary index is spatiotemporal in nature: it is reduced by anxiolytic drugs and can be increased by anxiogenic compounds 32 . The decrease in time spent on the central platform is another indication of reduced “decision-making” behaviour. Both parameters are accepted as reliable indicators of anxiety and fearfulness 33 .

PECB at medium and high doses (600 and 800mg/kg), but not the lower dose (400mg/kg) had increased the time spent in and number of entries into open arms with a decreased time spent and number of entries into closed arms. After treatment with all three doses in different groups the total numbers of entries into both open and closed arms were decreased insignificantly as compared to control group but except with the low dose (400mg/kg). It can be suggest that, the higher doses of PECB may have the sedative effect more than the standard drug and as a result animals spent more time in open, closed arms & less time in central platform, while standard drug treated animals spent more time in open arm & central platform but less time in closed arm. Lower dose of PECB (400mg/kg) didn't alter the above parameters significantly; suggesting that 400mg/kg of PECB had not exhibiting anxiolytic effect. Therefore, behavioral alterations induced by medium and higher dose of PECB (600 and 800mg/kg) were consistent with anxiolytic activity. The three dose of PECB (400,600 and 800mg/kg) showed dose depended anxiolytic profile. The lower dose of PECB (400mg/kg) didn't exhibit any anxiolytic activity.

Standard drug diazepam act selectively on GABAA receptors which mediate fast inhibitory synaptic transmission throughout the CNS. Benzodiazepines (BDZs) bind to the gamma sub-unit of the GABA-A receptor, that causes an allosteric (structural) modification of the receptor results with an increase in GABA A receptor activity. BDZs do not substitute for GABA, which bind at the alpha sub-unit, but increase the frequency of channel opening events which leads to an increase in chloride ion conductance and inhibition of the action potential. These drugs also exert a marked taming effect, allowing animals to be handled more easily 34 .

Hole-board model indicated that head-dipping behaviour was sensitive to changes in the emotional state of the animal, and suggested that the expression of an anxiolytic state in animals may be reflected by an increase in head-dipping behaviour 36 .The PECB medium and high doses (600 & 800mg/kg) shows increase in number, latency and duration of head dipping and the number of rearing in the hole board test. It could be argued that the increased head-dipping in rats is merely an artifact of the hyperactivity induced by the drug. But the effect of low dose (400mg/kg) was found to be insignificant when compared with control. There is a significant reduction in defecation units seen with the high dose (800mg/kg), but not with medium and low doses (600& 400mg/kg) respectively. Diazepam a putative anxiolytic agent increased the number, latency and duration of head dipping and the number of rearing with reduction in defecation units as also noted with PECB medium & high (600 & 800mg/kg) doses. Therefore the increased number of head dippings & rearings are not only a representation of hyperactivity but also a reflection of anxiolytic effect.

It has been suggested that some animal models based on spontaneous behaviour or ethologically based models 37 like the light-dark test, may be more sensitive to the behavioural responses than conditioned paradigms 38 .

The light-dark test may be useful to predict the anxiolytic like activity of drugs in mice. It has the advantages of being quick and easy to use without food and water deprivation prior training of animals and natural stimuli are used. Transitions have been reported to be an index of activity exploration because of habituation over time and the time spent in each compartment to be a reflection of aversion 39 .

In Light-Dark Transition test, the apparatus contains two compartments i.e. light and dark. Animals always try to spend more time in dark compartment because of fear about new environment. In this model, four behavioral events were observed i.e. number of crossings to light compartment, time spent in light and dark box, number of rearings in light and dark box and defecation units. In this study high doses (800mg/kg) of PECB had significantly increased the time spent in light compartment along with reduced time spent in dark compartment, number of crossings and decreased the number of rearings in light as well as dark compartments, indicating that high dose of PECB had produced significant anxiolytic effect but not medium & lower dose (600 & 400mg/kg). Medium dose (600mg/kg) had shown decreased rearings in dark compartment, but the effects on remaining parameters were insignificant as compared with control.

It is well known that BZDs have sedative, anticonvulsant, anxiolytic and hypothermic effect. Anxiolytics are known to exert pharmacological action by causing an increase in GABA content in the cerebral hemisphere 40 .

Several lines of evidence show that natural and synthetic flavonoids are potent anxiolytic agents without sedative, myorelaxant or amnestic effects. It is known the participation of GABA in these effects 41 .

Conclusion

The results obtained from these experimental models clearly confirmed the anxiolytic activities of PECB. Phytoconstituents like flavonoids and saponins were reported for their anxiolytic effect and these two were present in petroleum ether extract. So these active principle might be responsible for anxiolytic effects.

Acknowledgement

Authors are thankful to the management of AME's society for providing the facilities to carry out this work.

Correspondence to

N.Venkat Rao, Professor & Head, Dept of Pharmacology, V.L. College of Pharmacy, Manikprabhu Temple Road, Raichur-584103. Mobile- 09845666548 Email: shalam26@yahoo.co.in Fax : 08532240405

References

1. Mukherjee P, Roy U. Neuropharmacological profile of herbal medicine formulation. Ind J Med Res 1990; 84: 227-232.
2. Sen P, Mediratta PK, Ray A. Effects of Azadirachta indica on some biochemical, immunological and visceral parameters in normal and stressed rats. Ind J Exp Biol 1992; 30:1170-1175.
3. Ernst. Herbal remedies for anxiety a systematic review of controlled clinical trials. Phytomed 2004; 1(4):3.
4. Rabbani M, Sajjadi S, Ezarei HR. Anxiolytic effects of Stachys lavandulifollia on the elevated plus- maze model of anxiety in mice. J Ethnopharmacol 2003; 89: 271-276.
5. Lavie CJ, Milani RV. Prevalence of anxiety in coronary patients with improvement in following cardiac rehabilitation and exercise training. Amer J Cardiol 2004; 93:336-339.
6. Oliver B, Wijngarden LV, Soudijin W. 5-HT receptors antagonist and anxiety. Eur Neuro Psychopharmacol 2000; 10:77-95.
7. Handa SS, Koslow SH, Murthi RS, Coelho GV. Plant and plant products for mental health. U.S.Deptt of Health and Human Services 1995; 163-171.
8. Eisenberg DM, Davis RB, Ettner SL, Appeal S, Willkey S, Vanrompay M, Kessler RC. Trends in alternative medicines used in United States. J Amer Med Assoc 1990; 280:1569-1575.
9. Kirtikar and Basu, Indian medicinal plants-1991; 2:842-845.
10. Kokate CK., Purohit AP., Gokhale SB. Text book of of Pharmacognosy, Nirali Prakashan, Pune. 1996; 4: 510-11.
11. Trease GE., Evans MC. "Text book of Pharmacognosy" London, BailliareTindall; 1983; 12:193,336.
12. Khandelwal KR. "Practical Pharmacognosy.Techniques and Experiments" Pune, Nirali Prakashan, 2000; 2:149-155.
13. Kokate CK. "Practical Pharmacognosy", New Delhi, Vallabh Prakashan 1994; 4:110-111.
14. OECD 2001-gudeline on acute oral toxicity (AOT) Environmental health and safety monograph series on testing and adjustment No.425.
15. Vogel H, Gerhard, Vogel Wolf gang H. (Eds) Drug discovery and evaluation pharmacological assays (Springer).Germany. 2000; 2: (E). 235.
16. Hogg SA. Review of the validity and Variability of the elevated plus-maze as an animal model of anxiety. Pharmacol.Biochem.Behav. 1996; 54: 21-30.
17. Pellow S, File SE. Anxiolytic and axiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986; 24: 525-529.
18. Kulkarni SK. Handbook of Experimental pharmacology. 3rd edition, Vallabh Prakashan 1999: 135.
19. Rodgers RJ, Johnson NJT. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol.Biochem.Behav.1998; 59: 221-232
20. Soman I, Mengi SA, Kasture SB. Effects of leaves of Butuea frondosa on stress, anxiety and cognition in rats. J Pharmacol Biochem Behav 2004; 79:11-16.
21. Zanoli P, Avallone R, Baraldi M. Behavioral characterization of the flavonoids apigenin and chrysin. Fitoterapia 2000; 71: S117-S123.
22. Maribel HR. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 2006; 107: 53-58.
23. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980; 13: 167
24. Thiebot MH, Soubrie P, Simon P, Boissier JR. Dissociation de deux composantes du comportement chez le Rat sous l effet de psychotropes. Application a l etude des anxiolytiques. Psychopharmacologia; 1973; 31:77-90.
25. Simiand J, Keane PE, Morre M. The staircase test in mice: A simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology: 1984; 84:48-53.
26. Dawson GR, Tricklebank MD. Trends pharmacol Sci 1995; 16: 33-36.
27. Kulkarni SK., Reddy DS. Methods Find Exp Clin Pharmacol 1996; 18: 219-230.
28. Soderphalam R, Hjorth S, Engel JA. Effect of 5HT1A receptor agonists and L-5 HTP in Montgomery's conflict test. Pharmacol Biochem Behav 1989; 32: 259-26.
29. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14:149.
30. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92:180.
31. Montgomery KC. The relation between fear induced by novel and exploratory behaviour. J Comp Physiol Psychol 1955; 48: 254-60.
32. Gupta M, Mazumder UK, Kumar RS, Siva kumar T, Vamsi ML. Antitumour activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in swiss albino mice. J Pharmacol Sci 2004; 94(2):177-184.
33. Saeed MA, Sabir AW. Antibacterial activity of Caesalpinia bonducella seed. Fitoterpia 2001; 72(7):807-809.
34. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology, 5th edition, London, Churchill Livingstone, 2003: 515-524.
35. Broadhurst, Felicio, Nasello et al. J Ethnopharmacol 1987; 72:61-67.
36. Takeda H., Tsuji M., Matsumiya T. Changes in head-dipping behavior in the hole-board test reflects the anxiogenic and/or anxiolytic state in mice.Eur J Pharmacol 1998; 350:21-29.
37. Soderphalam R, Hjorth S, Engel JA. Effect of 5HT1A receptor agonists and L-5 HTP in Montgomery's conflict test. Pharmacol Biochem Behav 1989; 32: 259-26.
38. Griebel G, Lanfumey L, Blanchard DC, Rettori MC, Guaardiola LB, Hamon M. Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S21357. Pharmacol Biochem Behav 1996; 54:509-516.
39. Belzung C, Misslin R, Vogel E, Dodd RH, Chapounthier G. Anxiogenic effects of methyl-?carboline-carboxylate in a light-dark choice situation. Pharmacol
Biochem Behav 1987; 28:29-33.
40. Makota T, Tsutomu S, Miwa M, Hiroshi N. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Euro J Pharmacol 1996; 307:7-14.
41. Haberlein H, Tschiersch KP, Schafer HL. Flavonoids from Leptospermum scoparium with affinity to the benzodiazepine receptor characterised by structure activity relation ships and in vivo studies of plant extract. Pharmazie 1994; 49(12): 912-922.

Author Information

Altaf Ali
Department of Pharmacology, V.L. College of Pharmacy

N. Venkat Rao
Department of Pharmacology, V.L. College of Pharmacy

Md. Shalam
Department of Pharmacology, V.L. College of Pharmacy

T. Shivaraj Gouda
Department of Pharmacology, V.L. College of Pharmacy

Jeevan Mane Babu
Department of Pharmacology, V.L. College of Pharmacy

S.M. Shantakumar
Department of Pharmachemistry, V.L. College of Pharmacy

Your free access to ISPUB is funded by the following advertisements:

Advertisement
BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy